Laser-Induced Blood-Brain Barrier Disruption for Liposome Delivery into a Mouse Model of Glioblastoma
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 1:26 min • August 7th, 2025
Begin with a mouse model of glioblastoma, an invasive brain tumor.
At the tumor periphery, the blood-brain barrier (BBB) remains intact, with endothelial cells forming tight junctions that regulate molecular entry.
The mouse is fitted with a head-mounted optical fiber to deliver laser light.
Administer a low-intensity infrared laser, which penetrates the skin and skull to reach the brain.
The laser excites molecular oxygen in brain cells, generating reactive oxygen species (ROS).
The resulting oxidative stress disrupts tight junctions and increases BBB permeability.
Fluid leakage through the BBB enhances the flow of interstitial fluid (ISF), which surrounds brain cells and blood vessels.
Intravenously inject a suspension of liposomes, which are nano-sized vesicles designed for drug delivery.
The liposomes cross the disrupted BBB, and the enhanced ISF flow facilitates their distribution and accumulation within the tumor.
Over time, the expression of tight junction proteins restores BBB integrity and prevents further leakage.
Overview
This study investigates the effects of low-intensity infrared laser light on the blood-brain barrier (BBB) in a mouse model of glioblastoma. The laser induces oxidative stress that disrupts tight junctions, enhancing BBB permeability and facilitating drug delivery to the tumor.
Key Study Components
Area of Science
- Neuroscience
- Oncology
- Drug Delivery Systems
Background
- Glioblastoma is an aggressive brain tumor with a complex microenvironment.
- The blood-brain barrier (BBB) protects the brain but complicates drug delivery.
- Understanding BBB dynamics can improve therapeutic strategies.
- Laser-induced oxidative stress may alter BBB integrity.
Purpose of Study
- To explore the impact of laser light on BBB permeability.
- To assess the potential for enhanced drug delivery to glioblastoma.
- To evaluate the restoration of BBB integrity over time.
Methods Used
- Mouse model of glioblastoma with head-mounted optical fiber.
- Application of low-intensity infrared laser to excite molecular oxygen.
- Measurement of reactive oxygen species (ROS) generation.
- Intravenous injection of liposomes for drug delivery assessment.
Main Results
- Laser application increased BBB permeability through oxidative stress.
- Enhanced interstitial fluid flow facilitated liposome distribution.
- Tight junction protein expression was restored over time.
- Drug delivery to the tumor was significantly improved.
Conclusions
- Low-intensity laser light can effectively disrupt BBB integrity.
- This method enhances the delivery of therapeutic agents to glioblastoma.
- Restoration of BBB integrity may limit further leakage post-treatment.
Frequently Asked Questions
Executive Industry Relevance
Laser-induced blood-brain barrier disruption offers a non-invasive strategy to enhance drug delivery in glioblastoma, addressing a critical bottleneck in CNS therapeutics. By enabling transient BBB opening via controlled oxidative stress, this approach supports improved accumulation of nanocarriers like liposomes in tumor tissue. The method provides a mechanistic foundation for evaluating drug delivery platforms in preclinical models with intact but restrictive barriers.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic access hypotheses by modulating BBB permeability in vivo.
- Operational Value: Provides a reproducible physiological model to assess target engagement under altered barrier conditions.
Screening & Assay Development
- Scientific Value: Facilitates preparation of validated biological systems for liposome or nanoparticle screening under enhanced permeability conditions.
- Operational Value: Supports standardization of drug delivery assays by controlling a key physiological variable—BBB integrity.
Translational & Preclinical Research
- Scientific Value: Aligns with disease-relevant systems by modeling BBB dynamics in glioblastoma, aiding translational biomarker evaluation.
- Operational Value: Enables risk-adjusted advancement decisions by quantifying nanocarrier delivery efficiency preclinically.
Pipeline & Workflow Integration
This method fits within the discovery continuum from target validation through lead identification to preclinical evaluation, particularly for CNS-targeted modalities where BBB penetration is a limiting factor.
- Discovery Biology: Supports hypothesis testing regarding target accessibility and pathway modulation under altered barrier states.
- Screening: Enhances assay readiness by enabling controlled BBB disruption for consistent nanocarrier evaluation.
- Analytics: Generates quantitative readouts on liposome accumulation and distribution, supporting comparative condition analysis.
- Translational Research: Connects discovery to preclinical continuity by modeling a key physiological barrier in glioblastoma.
- Enterprise Reuse: Represents a reusable capability for evaluating diverse drug delivery platforms across neuroscience oncology projects.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in CNS drug delivery by reducing mechanistic ambiguity around barrier penetration.
- Operational Value: Improves reproducibility and scalability of permeability-modulating techniques in preclinical workflows.
- Strategic Value: Informs go/no-go decisions by providing early insight into delivery efficiency, reducing late-stage failure risk.
- Portfolio Impact: Enables risk-adjusted prioritization of nanotherapeutic candidates based on validated BBB transit data.
Implementation Considerations
- Requires expertise in neuro-oncology models and optical delivery systems.
- Depends on laser instrumentation capable of precise, low-intensity infrared application.
- Necessitates standardization across laboratories for consistent ROS generation and BBB disruption metrics.
- Involves adaptation considerations when translating from murine models to larger preclinical systems.
- Limited by the transient nature of BBB opening, requiring timed drug administration for optimal effect.
Biopharma FAQs
A Benchtop Approach to the Location Specific Blood Brain Barrier Opening using Focused Ultrasound in a Rat Model
Related Videos
0 Views
Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation
Related Videos
0 Views
Real-Time Intravital Multiphoton Microscopy to Visualize Focused Ultrasound and Microbubble Treatments to Increase Blood-Brain Barrier Permeability
Related Videos
0 Views
Enhancing Drug Delivery in Recurrent Glioblastoma with Laser-Induced Hyperthermia
Related Videos
0 Views
Intravenous Administration of Therapeutic Nanoparticles in a Murine Glioblastoma Model
Related Videos
0 Views
Assessing Blood-Brain Barrier Integrity in a Laser-Induced Brain Injury Rat Model
Related Videos
0 Views
Bioluminescence Imaging of an Immunocompetent Mouse Model for Glioblastoma
Related Videos
0 Views
An Orthotopic Glioblastoma Mouse Model Maintaining Brain Parenchymal Physical Constraints and Suitable for Intravital Two-photon Microscopy
Related Videos
0 Views
Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish
Related Videos
0 Views
Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion
Related Videos
0 Views
Last updated: 22 August 2026